Long-acting Injectable Medications Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

The Global Long-acting Injectable Medications Market size is projected to reach USD million by 2027, from USD million in 2020, at a CAGR of 5% during 2021-2027.

Long-acting injectables (LAIs) are a unique tool used by psychiatric pharmacies to help improve patient outcomes. They offer many advantages over oral therapy, including confirmed patient compliance, consistent drug delivery, predictable bioavailability, and prevention of antipsychotic drug overdose. It originates from indications such as schizophrenia and contraception, treatment and prevention of HIV.

Market Segments

On the basis of product

• First-generation
• Second-generation

On the basis of the end users

• Schizophrenia
• Contraception
• HIV
• Others

Key Players

• Mapi Pharma
• Pharmathen
• Kashiv BioSciences
• DURECT
• Zogenix
• GSK
• Nanomi
• MedinCell
• Alkermes
• Oakwood Labs

Scope of the Report

The research study analyzes the global Long-acting Injectable Medications industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Long-acting Injectable Medications Market Report

1. What was the Long-acting Injectable Medications Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of the Long-acting Injectable Medications Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Long-acting Injectable Medications Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.